The purpose of this study is to evaluate the efficacy and safety of NNC0487-0111 compared to placebo on morbidity and mortality in people with heart failure with preserved or mildly reduced ejection fraction and obesity
Contact phone
517-364-5760
Contact email
[email protected]
Principal investigator
Dr. John Ip, MD
Trial Category
Heart & Vascular
Trial SubCategory
Cardiovascular Disease
Webform